1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone has been researched along with l 365260 in 3 studies
| Studies (1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone) | Trials (1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone) | Recent Studies (post-2010) (1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone) | Studies (l 365260) | Trials (l 365260) | Recent Studies (post-2010) (l 365260) |
|---|---|---|---|---|---|
| 26 | 0 | 5 | 422 | 10 | 8 |
| Protein | Taxonomy | 1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone (IC50) | l 365260 (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0081 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.0081 | |
| Cholecystokinin receptor type A | Rattus norvegicus (Norway rat) | 0.4981 | |
| Gastrin/cholecystokinin type B receptor | Rattus norvegicus (Norway rat) | 0.039 | |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.0081 | |
| Histamine H1 receptor | Cavia porcellus (domestic guinea pig) | 5 | |
| Cholecystokinin receptor type A | Homo sapiens (human) | 0.1585 | |
| Gastrin/cholecystokinin type B receptor | Homo sapiens (human) | 0.0079 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 5 | |
| Cholecystokinin receptor type A | Cavia porcellus (domestic guinea pig) | 0.044 | |
| Cysteinyl leukotriene receptor 2 | Homo sapiens (human) | 5 | |
| Cysteinyl leukotriene receptor 1 | Homo sapiens (human) | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanchard, JC; Böhme, GA; Lemaire, M; Piot, O; Roques, BP | 1 |
| Czachura, JF; Howbert, JJ; Rasmussen, K; Stockton, ME | 1 |
| Ding, XQ; Håkanson, R | 1 |
3 other study(ies) available for 1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone and l 365260
| Article | Year |
|---|---|
CCK-A and CCK-B selective receptor agonists and antagonists modulate olfactory recognition in male rats.
Topics: Amino Acid Sequence; Animals; Benzodiazepinones; Cholecystokinin; Cognition; Indoles; Male; Meglumine; Molecular Sequence Data; Peptide Fragments; Phenylurea Compounds; Pyrazoles; Rats; Rats, Wistar; Receptors, Cholecystokinin; Sincalide; Smell; Social Behavior | 1994 |
Electrophysiological effects of diphenylpyrazolidinone cholecystokinin-B and cholecystokinin-A antagonists on midbrain dopamine neurons.
Topics: Animals; Benzodiazepinones; Cholecystokinin; Dopamine; Electrophysiology; Male; Mesencephalon; Neurons; Phenylurea Compounds; Pyrazoles; Rats; Rats, Sprague-Dawley | 1993 |
Evaluation of the specificity and potency of a series of cholecystokinin-B/gastrin receptor antagonists in vivo.
Topics: Analysis of Variance; Animals; Anti-Ulcer Agents; Benzodiazepines; Benzodiazepinones; Dose-Response Relationship, Drug; Female; Gastric Emptying; Gastric Mucosa; Histidine Decarboxylase; Hormone Antagonists; Infusions, Intravenous; Lethal Dose 50; Male; Mice; Phenylurea Compounds; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Structure-Activity Relationship | 1996 |